EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Exploring a distinct FGFR2::DLG5 rearrangement in a low-grade neuroepithelial tumor: A case report and mini-review of protein fusions in brain tumors

Paola Loreto Palacio, Xiaokang Pan, Dan Jones, José Javier Otero iD

Journal of Neuropathology & Experimental Neurology · 2024

DOI: 10.1093/jnen/nlae040 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2024. Verfasst von Paola Loreto Palacio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Abigail Wexner Center Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Receptor, Fibroblast Growth Factor, Type 2, Neoplasms, Neuroepithelial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the novel clinical presentation of a primary brain neoplasm in a 30-year-old man with a mass-like area in the anteromedial temporal lobe. Histopathological analysis revealed a low-grade neuroepithelial tumor with cytologically abnormal neurons and atypical glial cells within the cerebral cortex. Molecular analysis showed a previously undescribed FGFR2::DLG5 rearrangement. We discuss the clinical significance and molecular implications of this fusion event, shedding light on its potential impact on tumor development and patient prognosis. Additionally, an extensive review places the finding in this case in the context of protein fusions in brain tumors in general and highlights their diverse manifestations, underlying molecular mechanisms, and therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsReceptor, Fibroblast Growth Factor, Type 2Neoplasms, NeuroepithelialHumansMaleAdultOncogene Proteins, Fusion

Stichwörter der Autor:innen

FGFR2::DLG5 fusionBrain tumorFGFR2Low-grade neuroepithelial tumor

Substanzen

Receptor, Fibroblast Growth Factor, Type 2FGFR2 protein, humanOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Abigail Wexner Center Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • James Molecular Laboratory, James Cancer Hospital, Columbus, Ohio, USA.
  • The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Neuropathology Division, Pathology Department, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

ORCID-Profile: José Javier Otero

Zitieren

APA

Loreto Palacio, P., Pan, X., Jones, D., & Otero, J. J. (2024). Exploring a distinct FGFR2::DLG5 rearrangement in a low-grade neuroepithelial tumor: A case report and mini-review of protein fusions in brain tumors. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlae040

Vancouver

Loreto Palacio P, Pan X, Jones D, Otero JJ. Exploring a distinct FGFR2::DLG5 rearrangement in a low-grade neuroepithelial tumor: A case report and mini-review of protein fusions in brain tumors. Journal of Neuropathology & Experimental Neurology. 2024. doi:10.1093/jnen/nlae040

BibTeX
@article{LoretoPalacio2024,
  author = {Loreto Palacio, Paola and Pan, Xiaokang and Jones, Dan and Otero, José Javier},
  title = {Exploring a distinct FGFR2::DLG5 rearrangement in a low-grade neuroepithelial tumor: A case report and mini-review of protein fusions in brain tumors},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2024},
  doi = {10.1093/jnen/nlae040}
}
Kostenlos starten →